{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-000317","form_type":"8-K","ticker":"XERS","cik":"0001867096","company_name":"Xeris Biopharma Holdings, Inc.","filed_at":"2022-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.943378+00:00","generated_at":"2026-06-27T21:29:40.151171+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Xeris Biopharma raises $30M in private placement with Armistice Capital","bullets":["Gross proceeds of $30M from sale of 10.2M shares at $2.93/share (closing price Dec 31, 2021).","Warrants to purchase up to 5.1M shares at $3.223/share, exercisable immediately for 5 years.","Net proceeds to support operations, commercial products, clinical trials, working capital.","Private placement expected to close Jan 3, 2022; resale registration statement to be filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-000317","json":"https://secwatch.observer/filing/0001193125-22-000317.json","markdown":"https://secwatch.observer/filing/0001193125-22-000317.md","text":"https://secwatch.observer/filing/0001193125-22-000317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867096/000119312522000317/0001193125-22-000317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867096/000119312522000317/d221763d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T21:29:40.151171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}